, Tracking Stock Market Picks
Enter Symbol:
Alkermes, Inc. (ALKS) [hlAlert]

Mkt Perform

Alkermes, Inc. (ALKS) downgraded to Mkt Perform by Leerink Swann

Posted on: Tuesday,  Apr 7, 2009  9:25 AM ET by Leerink Swann

Leerink Swann rated Mkt Perform Alkermes, Inc. (NASDAQ: ALKS) on 04/07/2009. Previously Leerink Swann rated Outperform
Alkermes, Inc. (NASDAQ: ALKS) on 03/03/2009., when the stock price was $9.38. Since then, Alkermes, Inc. has lost 9.17% of its value until Leerink Swann rated ALKS Outperform on 04/07/2009, when the price was $8.52. .

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/29/2013 8:25 AM Buy
as of 12/31/2009
1 Week up  31.13 %
1 Month up  39.75 %
3 Months up  46.27 %
1 YTD up  37.11 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2009 8:25 AM Buy
4/7/2009 9:25 AM Hold
3/3/2009 8:25 AM Buy
9.38 13.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy